Log in to save to my catalogue

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b01b1c35c2c4311bda6e7bc3f0a87b4

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

About this item

Full title

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Publisher

United States: Elsevier Inc

Journal title

Molecular therapy. Oncolytics, 2015-01, Vol.1 (C), p.14006-14006, Article 14006

Language

English

Formats

Publication information

Publisher

United States: Elsevier Inc

Subjects

Subjects and topics

More information

Scope and Contents

Contents

Successful cancer control relies on overcoming resistance to cell death and on activation of host antitumor immunity. Oncolytic viruses are particularly attractive in this regard, as they lyse infected tumor cells and trigger robust immune responses during the infection. However, repeated injections of the same virus promote antiviral rather than a...

Alternative Titles

Full title

Overcoming tumor resistance by heterologous adeno-poxvirus combination therapy

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_9b01b1c35c2c4311bda6e7bc3f0a87b4

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_9b01b1c35c2c4311bda6e7bc3f0a87b4

Other Identifiers

ISSN

2372-7705

E-ISSN

2372-7705

DOI

10.1038/mto.2014.6

How to access this item